Overview
The 20-Week Breakout scanner logged 121 total signals on 2026-09-17, split between 75 bullish (dollar_20_wk + pct_20_wk) and 46 bearish (dollar_d20_wk + pct_d20_wk) triggers. That puts the bullish share at approximately 62%, landing in the balanced-to-bullish zone rather than a decisive institutional stampede. Sentiment data reads Very Bullish/Neutral against a broader SA Regime of Cautious-Bearish, with only 32.0% of names above their SMA-40 — a breadth/sentiment mismatch that argues for selectivity over broad exposure.
Sector leadership confirms the caution: Health Care (+1.7% ATR%), Energy (+0.4%), and Communication Services (+0.2%) are the only sectors with positive average true range expansion, while Industrials, Real Estate, and Utilities are firmly negative. This narrow leadership is echoed in the breakout list, where Medical/Health Care names dominate the bullish board.
Quality Score: 3/5. Per regime rules, Cautious-Bearish conditions cap conviction at 3 despite strong individual ATR multiples (several names above 3.0–7.5x). Institutional fund counts are reported as 0 across every signal in this dataset, removing a key confirmation layer. Until breadth improves and fund accumulation data confirms follow-through, treat these as tactical, sector-anchored trades rather than broad-based conviction buys.
Top 5 Bullish Picks
AMD ($545.09) — CHIPS / Elec-Semicondctor Fablss
AMD posted a $-magnitude weekly breakout with a 2.23 ATR Multiple on in-line relative volume (1.1x), sitting just 6.8% off its 52-week high and up 263.8% off its 52-week low. ADR% of 3.5% and LOD Risk ATR% of 71.3% indicate a healthy, sustainable trend rather than a blow-off move.
| Level | Price |
|---|---|
| Entry/Current | $545.09 |
| Stop (2x ATR) | $496.21 |
| Target 1 (2x ATR) | $593.97 |
| Target 2 (4x ATR) | $642.85 |
Institutional Interest: 0 funds tracked, funds % increase undefined; classified in all_unique_bucket_1_stocks — momentum-led, not yet fund-confirmed.
STRL ($505.72) — BUILDING / Bldg-Heavy Construction
STRL’s dollar breakout came against a negative ATR Multiple (-1.52) and light relative volume (0.9x), a divergent signal given Industrials sits at the bottom of sector rankings. The stock remains 49.7% below its 52-week high, suggesting this is a counter-trend bounce that requires tight risk control.
| Level | Price |
|---|---|
| Entry/Current | $505.72 |
| Stop (2x ATR) | $443.12 |
| Target 1 (2x ATR) | $568.32 |
| Target 2 (4x ATR) | $630.92 |
Institutional Interest: 0 funds tracked; bucket all_unique_bucket_1_stocks. Treat as speculative given sector headwinds.
FFIV ($434.62) — INTERNET / Internet-Network Sltns
FFIV broke out just 0.2% from its 52-week high with a 2.29 ATR Multiple and steady ADR% of 3.3%. Volume of 515,310 came in slightly below average (0.8x), but the tight proximity to highs shows constructive accumulation.
| Level | Price |
|---|---|
| Entry/Current | $434.62 |
| Stop (2x ATR) | $406.50 |
| Target 1 (2x ATR) | $462.74 |
| Target 2 (4x ATR) | $490.86 |
Institutional Interest: 0 funds tracked; bucket funds_1000, indicating this name sits in a broader fund-monitored universe even without a confirmed fund count today.
ILMN ($245.18) — MEDICAL / Medical – Research
ILMN is a standout with a 5.05 ATR Multiple and elevated relative volume of 1.9x, trading just 3.9% below its 52-week high and up 178.6% from its low. This aligns directly with Health Care’s sector leadership (+1.7% ATR%), the strongest tailwind in the current regime.
| Level | Price |
|---|---|
| Entry/Current | $245.18 |
| Stop (2x ATR) | $225.08 |
| Target 1 (2x ATR) | $265.28 |
| Target 2 (4x ATR) | $285.38 |
Institutional Interest: 0 funds tracked; bucket funds_1000 — highest conviction on the list given sector alignment.
DELL ($588.49) — COMPUTER / Computer-Hardware/Perip
DELL surged with a 4.86 ATR Multiple and above-average volume (1.2x, 9.14M shares), sitting only 2.0% off its 52-week high and up a massive 433.9% from its low. ADR% of 5.9% signals strong intraday range expansion supporting continuation.
| Level | Price |
|---|---|
| Entry/Current | $588.49 |
| Stop (2x ATR) | $521.13 |
| Target 1 (2x ATR) | $655.85 |
| Target 2 (4x ATR) | $723.21 |
Institutional Interest: 0 funds tracked; bucket all_unique_bucket_1_stocks — strong price/volume confirmation despite no fund print today.
Bearish Alerts
Five names triggered dollar-based breakdowns: CBOE (Financial Svcs-Specialty, -2.05 ATR Multiple, 28.1% off highs), JBHT (Transportation-Truck, -3.29 ATR Multiple, elevated 1.8x relative volume), GS (Banks-Money Center, -2.72 ATR Multiple, 1.6x volume), AZO (Retail-Auto Parts, -2.11 ATR Multiple, sitting near 52-week lows at -0.2%), and LRCX (Semiconductor Equip, -2.20 ATR Multiple, 38.6% off highs). Financial Services and Banks showing simultaneous weakness (CBOE, GS) is notable and warrants defensive positioning in that group. LRCX’s breakdown also contrasts with AMD’s chip-sector strength, highlighting a bifurcation between semiconductor equipment and fabless design names.
Sector Theme
Health Care’s sector leadership (+1.7% ATR%) is the clearest theme, directly reflected in five bullish Medical signals (ILMN, TEM, WGS, WAT, LLY). Energy and Communication Services round out the leaders but show no representation in today’s Top 20-Week list. Conversely, Industrials, Real Estate, and Utilities are the weakest sectors (-2.3% to -2.7% ATR%) — STRL’s bullish Building signal is a notable outlier against this backdrop and should be sized cautiously. Chips shows internal divergence: AMD (fabless) strong, LRCX (equipment) weak.
Institutional Summary
Across all bullish and bearish signals reviewed, institutional fund counts are uniformly reported as 0 funds with undefined funds % increase — this dataset slice shows no confirmed fund-accumulation signal today. Bucket classifications (funds_1000 for FFIV, ILMN; all_unique_bucket_1_stocks for AMD, STRL, WAT, LLY, DELL) indicate these tickers remain on institutional watchlists even without a fresh fund print. Given the Cautious-Bearish regime and absent fund confirmation, today’s breakouts should be treated as price/volume-driven momentum plays rather than institutionally validated accumulation, reinforcing the capped Quality Score of 3.